Recent Advances in Molecular Pathways Targeted by Anti-Inflammatory Agents (NF-KB, NLRP3, JAK/STAT, MAPK)

Chronic inflammation is a hallmark of various diseases, including autoimmune disorders, cancer, and neurodegenerative diseases. Recent advances in understanding the molecular mechanisms underlying inflammation have led to the development of novel therapeutic strategies targeting key signaling pathways, including NF-KB, NLRP3, JAK/STAT, and MAPK. This review aims to provide an overview of the recent advances in these molecular pathways and their potential as therapeutic targets for anti-inflammatory agents.